TREAT PTSD VA Act

# Veterans' PTSD Treatment Bill Advances in Congress

Legislation aimed at expanding treatment options for veterans suffering from post-traumatic stress disorder has moved forward in Congress. The TREAT PTSD Act, which would provide veterans access to stellate ganglion block therapy—a minimally invasive procedure showing promise in treating PTSD symptoms—has been referred to the House Committee on Veterans' Affairs for consideration.

The bill builds on growing recognition that current PTSD treatments, while effective for many veterans, don't work for everyone. The Department of Veterans Affairs currently offers evidence-based therapies including cognitive processing therapy, prolonged exposure therapy, and eye movement desensitization and reprocessing. However, researchers have identified stellate ganglion block as a potential additional tool, particularly for veterans who haven't responded adequately to traditional approaches or who experience severe symptoms.

For Milwaukee-area veterans, this legislation could mean more personalized treatment options. Wisconsin is home to thousands of veterans, many of whom struggle with service-related trauma. Expanding the VA's toolkit for PTSD treatment could help reduce the burden on existing mental health services and provide faster relief for those in crisis. The procedure has shown encouraging results in clinical settings, with some studies indicating significant symptom reduction.

The bill's path through committee will determine whether veterans nationwide gain access to this treatment option in the coming months.